Pyrtriazoles, a Novel Class of Store-Operated Calcium Entry Modulators

Subscriber access provided by Kaohsiung Medical University

Article

Pyrtriazoles, a Novel Class of Store-Operated Calcium Entry Modulators: Discovery, Biological Profiling and In Vivo Proof-of-Concept Efficacy in Acute Pancreatitis Beatrice Riva, Alessia Griglio, Marta Serafini, Celia Cordero Sanchez, Silvio Aprile, Rosanna Di Paola, Enrico Gugliandolo, Dalia Alansary, Isabella Biocotino, Dmitry Lim, Giorgio Grosa, Ubaldina Galli, Barbara Niemeyer, Giovanni Sorba, Pier Luigi Canonico, salvatore cuzzocrea, Armando A. Genazzani, and Tracey Pirali J. Med. Chem., Just Accepted Manuscript • DOI: 10.1021/acs.jmedchem.8b01512 • Publication Date (Web): 22 Oct 2018 Downloaded from http://pubs.acs.org on October 23, 2018

Just Accepted “Just Accepted” manuscripts have been peer-reviewed and accepted for publication. They are posted online prior to technical editing, formatting for publication and author proofing. The American Chemical Society provides “Just Accepted” as a service to the research community to expedite the dissemination of scientific material as soon as possible after acceptance. “Just Accepted” manuscripts appear in full in PDF format accompanied by an HTML abstract. “Just Accepted” manuscripts have been fully peer reviewed, but should not be considered the official version of record. They are citable by the Digital Object Identifier (DOI®). “Just Accepted” is an optional service offered to authors. Therefore, the “Just Accepted” Web site may not include all articles that will be published in the journal. After a manuscript is technically edited and formatted, it will be removed from the “Just Accepted” Web site and published as an ASAP article. Note that technical editing may introduce minor changes to the manuscript text and/or graphics which could affect content, and all legal disclaimers and ethical guidelines that apply to the journal pertain. ACS cannot be held responsible for errors or consequences arising from the use of information contained in these “Just Accepted” manuscripts.

is published by the American Chemical Society. 1155 Sixteenth Street N.W., Washington, DC 20036 Published by American Chemical Society. Copyright © American Chemical Society. However, no copyright claim is made to original U.S. Government works, or works produced by employees of any Commonwealth realm Crown government in the course of their duties.

Page 1 of 89

Journal of Medicinal Chemistry

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

ACS Paragon Plus Environment

Journal of Medicinal Chemistry 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Page 2 of 89

Pyrtriazoles, a Novel Class of Store-Operated Calcium Entry Modulators: Discovery, Biological Profiling and In Vivo Proof-of-Concept Efficacy in Acute Pancreatitis Beatrice Riva1,4#, Alessia Griglio1#, Marta Serafini1, Celia Cordero-Sanchez1, Silvio Aprile1, Rosanna Di Paola2, Enrico Gugliandolo2, Dalia Alansary3, Isabella Biocotino1, Dmitry Lim1, Giorgio Grosa1, Ubaldina Galli1, Barbara Niemeyer3, Giovanni Sorba1, Pier Luigi Canonico1, Salvatore Cuzzocrea2, Armando A. Genazzani1*, Tracey Pirali1,4*@ 1

Department of Pharmaceutical Sciences; Università del Piemonte Orientale; Novara, 28100;

Italy;

2

Department of Chemical, Biological, Pharmaceutical and Enviromental Sciences;

Università di Messina; Messina, 98166; Italy; 3 Department of Molecular Biophysics; Saarland University CIPMM; Homburg, 66421; Germany; 4 ChemICare S.r.l.; Enne3; Novara, 28100; Italy.

# contributed equally * contributed equally @ Corresponding Author: Prof. Tracey Pirali Dept. of Pharmaceutical Sciences Università del Piemonte Orientale Largo Donegani, 2 – 28100 Novara


1

Page 3 of 89 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60


Phone: 0039-0321-375852 Fax: 0039-0321-375821 e-mail: [email protected]


2


Page 4 of 89

ABSTRACT In recent years, channels that mediate Store-Operated Calcium Entry (SOCE, i.e. the ability of cells to sense a decrease in endoplasmic reticulum luminal calcium and induce calcium entry across the plasma membrane) have been associated to a number of disorders, spanning from immune disorders to acute pancreatitis and have been suggested to be druggable targets. In the present contribution, we exploited the click chemistry approach to synthesize a class of SOCE modulators where the arylamide substructure, that characterizes most inhibitors so far described, is substituted by a 1,4-disubstituted 1,2,3-triazole ring. Within this series, inhibitors of SOCE were identified and the best compound proved effective in an animal model of acute pancreatitis, a disease characterized by a hyperactivation of SOCE. Strikingly, two enhancers of the process were discovered, affording invaluable research tools to further explore the (patho)physiological role of capacitative calcium entry.

Introduction During evolution, Ca2+ ions were excluded from the cytosol to protect phosphate from precipitating.1 The very low concentration of Ca2+ in the cytosol, together with the massive gradient across membranes (Ca2+ is 105 times more abundant in organelles and in the extracellular medium compared to the cytosol), became thereafter an opportunity to use this ion as a specific second messenger. Ca2+-signals, defined as a transient rise of this ion in the cytosol, are now widespread transducers of signals, mediating various processes ranging from fertilization to cell death. A Ca2+-signal encodes a message through its amplitude, the duration and the frequency of its rises and the exact spatial localization in the cell. It has grown to such specialization that hundreds of proteins govern this process and each cell type has a unique set of proteins that are


3

Page 5 of 89 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60


chosen for specific tasks (the calcium toolkit, as defined by one of the fathers of modern calcium signalling).2 Given the importance of fine-tuning Ca2+-signals to generate highly specific signals, it is not surprising that a vast array of disorders is thought to have calcium dys-regulation as an underlying cause. As mentioned above, high concentrations of calcium are present in intracellular organelles (in particular in the ER/SR) and in the extracellular space and Ca2+-fluxes occur through channels located on the plasma membrane or on the membrane of intracellular organelles. Given that Ca2+pumps and exchangers are located on both membranes to extrude Ca2+ from the cytosol, it would be expected that the intracellular organelle pool would be soon depleted. It was already back in 1986 that Jim Putney, a pioneer of the cross-talk between the ER and the plasma membrane, formalized the hypothesis that a phenomenon known as “capacitative calcium entry” would exist that allows entry through the plasma membrane to refill the depleted organelles.3 The key experiment to exemplify capacitative calcium entry, or Store-Operated Calcium Entry (SOCE), as it is referred to nowadays, is depicted in Figure 1. In brief, emptying of the ER/SR store leads to opening of a plasma membrane channel through which Ca2+ can flow back in the cell and these two phenomena can be dissected by adding Ca2+ to the extracellular solution after the intracellular stores depletion. This simple, yet powerful, experimental approach remains valid to unmask the phenomenon in screenings. It is now thought that the principal components of SOCE are a Ca2+-sensor on the ER membrane (STIM proteins) and a plasma membrane Ca2+-channel (Orai channels).4 STIM proteins are singlespan membrane proteins, highly conserved across species. Two members of the family have been described, STIM1 and STIM2, of which the former appears more expressed. Orai channels reside on the plasma membrane channel and three members of the family (Orai1, Orai2, and Orai3) have


4


Page 6 of 89

been described, with Orai1 being the most abundant. It is important to stress that other crucial proteins participate in the SOCE process, including TRPC channels.5 Capacitative calcium entry, mediating the ISOC current,6 is not solely a replenishment mechanism, but also encodes cellular signals per se, regulating cytokine production, gene expression, cell growth, proliferation, differentiation and even cell death. Therefore, dysfunctions in this cellular event are implicated in a vast range of channelopathies, pointing to SOCE as a druggable target.7 The most important reason to pursue the search for specific SOCE inhibitors is the historically consolidated role played by capacitative calcium entry in autoimmunity8 and the paucity of welltolerated immunosuppressant drugs. Nevertheless, aberrant activity of SOCE is involved in a number of pathological states not limited to the immune system, ranging from neo-angiogenesis in cancer9 to acute pancreatitis.10 Last, genetic defects of STIM and Orai proteins have been described that give rise to loss- and gain-of-function genetic disorders mainly affecting the immune and skeletal systems, respectively.11 Specific pharmacological manipulation of SOCE has been challenging. For a long time, nonselective agents such as 2-APB,12 CAI13 and SKF-9636514 have been the primary experimental tools to modulate SOCE (Figure 2). Over the years, much interest has been directed at a series of 3,5-bistrifluoromethyl pyrazole derivatives, disclosed by Abbott in 2000.15 Specifically, BTP2 (Pyr2, YM-58483) is a potent inhibitor, but it has pleiotropic effects on both Orai and TRPC channels.16 Subsequently, other pyrazoles, identified as Pyrs, have been reported. Among them, Pyr3, a previously suggested selective inhibitor of TRPC3,17 was shown to inhibit both TRPC3and Orai1-mediated calcium entry. By contrast, two compounds, Pyr6 and Pyr10, are able to distinguish to a certain degree Orai and TRPC-mediated calcium entry.18


5

Page 7 of 89 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60


While the initial interest was mainly the discovery of experimental tools to gain insights into the role played by SOCE, drug development programs in this direction are currently underway.19 In this context, second-generation agents have been described with different characteristics in terms of mechanism of action and selectivity profile, including Synta66,20 RO2959,21 and GSK-7975A.22 Four SOCE inhibitors have entered clinical trials (CM2489 for psoriasis, CM4620 for acute pancreatitis, RP3128 for asthma and RP4010 for non-Hodgkin’s lymphoma), although none has reached regulatory approval and the advent of novel modulators would certainly increase the chances of clinical benefit. Interestingly, in silico screening of an FDA-approved drug library has recently led to the discovery of five compounds that can be either re-purposed or might serve as leads for future development of SOCE inhibitors.23 Besides negative modulators, SOCE potentiating agents have been reported. 2-APB is a wellknown, though not so selective, effector of SOCE, but it may either enhance or inhibit the current depending on concentrations,24 while MDEB, another borinate compound, has only a potentiating ability on ISOC.25 We now describe a new family of compounds, that we refer to as Pyrtriazoles,26 that is able to finetune SOCE and includes both inhibitors and enhancers. While the focus of our characterization is on the inhibitors, as these have immediate therapeutic applications, the positive SOCE modulators are to our knowledge the first SOCE enhancers that do not display a borinate substructure. Results Synthesis and rapid screening of compounds The work described in this paper stems from the observation that the arylamide substructure appears to be an essential pharmacophoric feature for SOCE modulation and almost all the inhibitors reported in the literature share this structural redundancy (Figure 2). Taking advantage


6


Page 8 of 89

of our extensive experience in click chemistry27 and its exploitation in drug discovery,28 we wondered whether the arylamide could be isosterically replaced by the 1,4-disubstituted 1,2,3triazole ring. To this aim, we started from the structure of known pyrazole derivatives, namely BTP2 and Pyr compounds,15-18 and isosterically substituted the amide moiety with the triazole ring (Scheme 1). The trifluoromethyl groups in the C3 and C5 positions of the pyrazole ring or, alternatively, the ethyl carboxylate group in the C4 position are necessary for the inhibitory activity and were kept fixed, while the portion beared by the triazole ring, which appears to contribute to selectivity, was extensively varied. To this aim, two pyrazolic azides 1 and 2 were prepared according to Scheme 2 and 3. The synthetic protocol was straightforward and afforded the two precursors in three steps: condensation, reduction of the aromatic nitro group to amine and diazotation-azidation. In the case of 2, the pyrazole was resistant to elimination of water and treatment with hydrochloric acid in boiling ethanol was necessary for dehydration/aromatization. Similarly, two pyrazolic alkynes 3 and 4 were prepared according to Scheme 4 and 5. The condensation reaction is followed by Sonogashira coupling with trimethylsilylacetylene and deprotection of the silyl group in the presence of TBAF. 1 and 2 were clicked with twenty-one different alkynes A-U and, similarly, 3 and 4 were coupled with twenty-one azides A-U (Table 1). The click reactions were performed under classical conditions on a 50 mg scale. In general, the reactivity of the two alkynes 3 and 4 was lower than the two corresponding azides 1 and 2, as demonstrated by a general decrease in the yields. Six reactions worked only in the presence of TBTA, a powerful stabilizing ligand for copper (I) that enhances its catalytic activity and favors the cycloaddition.29 Four reactions were not successful, even when TBTA was used.


7

Page 9 of 89 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60


Over the eighty-four performed reactions, seventy-nine products precipitated, were filtered, washed with water and heptane, characterized at this stage only by mass analysis and screened for activity on Store-Operated Calcium Entry in BV-2 cells, a mouse microglial cell line, using Fluo4 as a fluorimetric dye (Table 1). In brief, a multi-plate reader approach was employed in which intracellular stores of BV-2 cells were emptied with tBhQ (50 µM) in the presence of the compounds (at 10 µM). Calcium was then re-added after 600 sec to the extracellular medium and intracellular levels determined in a protocol similar to the one depicted in Figure 1. The use of crude compounds was possible as copper salts (CuI and CuII) up to 10 μM were devoid of any activity on SOCE (not shown) and it is therefore a time-efficient strategy to identify rapidly hit compounds. While false positives would be picked up in the characterization of purified compounds, we do acknowledge that it is possible, albeit unlikely, that false negatives might occur. Therefore, the twenty-three crude compounds that showed at least 20% difference of SOCE compared to control were re-synthesized, purified by column chromatography and re-tested by fluorescence microscopy using the ratiometric dye Fura-2 in BV-2 cells. Twelve compounds, ten that decreased SOCE and two that enhanced SOCE, that showed at least a 30% difference compared to control of SOCE were identified and tested also in Hek and Jurkat cells (Table 2). It is interesting to note that a carboxylic moiety in the R3 group, despite being absent in the previously reported Pyr compounds, is favourable for the modulation of SOCE within this new class of compounds, as demonstrated by the presence of this functional group in seven compounds over the twelve selected for their activity. On the other hand, substructures typically displayed by Pyrs (e.g. 3-fluoropyridine in Pyr6, Figure 2) do not confer a significant modulating activity on SOCE (2J, 4J, Table 1), corroborating that Pyrtriazoles are characterized by SARs substantially different from Pyrs. Overall, we can state that series 4 is the only one that does not display


8


Page 10 of 89

modulating activity on SOCE, while the other three series (1, 2, 3) comprise both negative and positive modulators, depending on the substituents R1 and R2 on the pyrazole ring, the R3 group and the relative position A or B of the triazole ring. Regarding R3, non-substituted phenyl ring and most of the exploited functionalized aromatic rings do not confer significant modulating activities. On the other hand, 4-(-3-carboxypropyl)phenyl (3D), 3-aminophenyl (1H, 3H), 4-hydroxy-3methoxyphenyl (1N) and 3-carboxyphenyl (1S, 2S, 3S) might yield an inhibitory character, according to the other functionalities featured by the compound. Curiously, the presence of a chlorine in para position (3G) confers a positive modulator character, while the carboxyl group in the same position might lead to a positive (2T) or a negative modulation (1T, 3T), depending on the substitution pattern displayed by the molecule. Characterization of the inhibitors We then performed concentration-response curves of 1S compared to Pyr3 in the three cell lines (see Supporting Information). The IC50 for inhibition in Hek cells for 1S was 0.6 ± 0.1 μM, in Jurkat cells 0.6 ± 0.1 μM, in BV-2 cells 4.9 ± 1.8 μM, compared to 0.5 ± 0.1, 0.3 ± 0.1 and 2.9 ± 0.8 μM, respectively, for Pyr3. Both 1S and Pyr3 were full inhibitors as 100 μM treatment led to a near abolishment of SOCE. This was true also for the other non-selected compounds that fully inhibited SOCE at 100 μM (not shown). The lower sensitivity of BV-2 cells (about 10-fold) may be accounted by the different source of cells (murine versus human), by the different isoform composition of Orai and STIM, as well as by a different Orai1/STIM1 ratio,30 or by a different level of Orai1 (indeed BV-2 appears to have 10-fold less Orai mRNA; not shown), although this was not investigated further. While the effect of Pyr3 and 1S at 10 µM on SOCE was similar as were the IC50s, differences were apparent when evaluating viability of cells after 24 h treatment. Viability of cells treated with Pyr3 10 µM was 28.6 ± 0.5% compared to 84.0 ± 1.0% of 1S. We


9

Page 11 of 89 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60


also tested Pyr6, which displayed an IC50 in Hek cells for SOCE inhibition of 0.3 ± 0.1 μM and a cell viability at 10 μM of 70.3 ± 5.8%. Therefore, it would appear that Pyr3 is the most cytotoxic, but some cytotoxicity is also displayed by its parent compound Pyr6 and by 1S, albeit at concentration 100-fold the IC50 for SOCE inhibition. Given that our cellular models also expressed TRPC1, we decided to investigate in Hek cells the contribution of TRPC1 in the observed Ca2+ influx. For this, we proceeded via shRNA experiments and were able to reduce mRNA expression of TRPC1 by 65 ± 13%. Partial silencing of TRPC1 in Hek cells slightly reduced SOCE by 11% (NS, p = 0.48; Figure 3B). The fact that 1S inhibited SOCE by about 90% in Hek cells (Table 2), together with the limited contribution of TRPC1 to SOCE, suggests that TRPC1 is not a target for our compounds. To further substantiate Orai/STIM as the target, we next used murine embryonic fibroblast (MEF) cells derived from wild-type or Stim1-/-/Stim2-/- mice.31 Wild-type cells had a similar expression profile of TRPC and Orai subtypes compared to Stim1-/-/Stim2-/- except for STIM expression (Figure 3C). As it can be observed in Figure 3D, tBhQ-triggered SOCE was low in the two cell lines, with some differences. Indeed, the peak of calcium entry was slightly higher in Stim1-/-/Stim2-/- MEFs. The presence of an initial rise in calcium in Stim1-/-/Stim2-/- MEFs contrasts to what reported previously in these cells31 and is unlikely to be attributable to SOCE, as it does not respond to 1S or Pyr3, unlike the initial rise observed in wild-type cells. It should be noted that the extent of calcium entry is small compared to what observed in all other cell types. Nonetheless, the biggest difference between Stim1-/-/Stim2/-

and wild-type MEFs was represented by the significant decrease in the plateau of calcium entry

in Stim1-/-/Stim2-/- MEFs. As expected, and in line with data in Figure 3A, in wild-type cells 1S significantly affected both the peak amplitude and the plateau. In contrast, in Stim1-/-/Stim2-/-


10


Page 12 of 89

MEFs, the peak amplitude was unaffected, while the prolonged phase was affected although to a lesser degree compared to wild-type. In line with SOCE measurements, ISOC measured in Hek cells co-overexpressing both Orai1 and STIM1 showed an inhibition of ~40% of current in cells treated with 10 µM 1S suggesting that the effects measured in SOCE are indeed mediated by Orai1 and STIM1 (Figure 3E). Characterization of the activators 2T and 3G To our great surprise, two of the synthesized compounds (2T and 3G) were able to enhance SOCE (Figure 4A, Table 2). Both compounds, tested at a concentration of 10 µM, significantly increased the AUC of calcium entry, the peak amplitude and the slope (Figure 4B) in Hek cells. A similar effect was also observed in BV-2 and Jurkat cells (not shown). The minor differences observed between the two compounds were probably attributable to the fact that 2T was more potent or efficacious. The effect of 2T was evident at concentrations above 0.3 µM and the effect of 3G was evident above 3 µM increased up to the highest concentration tested (100 µM; Figure 4C for Hek cells; see Supporting Information for concentration-response curves of 2T and 3G on all three cell lines). For this reason, IC50s of these compounds could not be calculated within the applied range of concentrations. To further investigate the mechanism of action, we performed electrophysiological recordings on Hek cells stably over-expressing Orai1 and transiently expressing STIM1. Both 2T and 3G were able to significantly potentiate ISOC measured in these cells using strong buffering conditions of the internal solution (20 mM BAPTA). Buffering the internal solution to contain 150 nM Ca2+ led to the abolishment of the potentiation of the current. However, in the latter conditions the kinetics of activation indicate that treatment with either 2T or 3G leads to faster activation of ISOC, as


11

Page 13 of 89 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60


indicated by the significantly reduced time constants of activation (Figure 4D). These data show that SOCE is the target of these compounds. In a similar manner to what described above, we decided to investigate whether the effect observed with 2T was attributable to Orai/STIM or to the potentiation of TRPC. In cells silenced for TRPC1, the potentiating effect observed by 2T was still evident, suggesting that Orai/STIM were the target of the agent (Figure 5A for wild type and 5B for shTRPC1). It should be noted that while AUC and peak amplitude were significantly different between control and 2T-treated cells, the slope was not modified in shTRPC1 (see Supporting Information). A direct or indirect effect on TRPC1 activity cannot therefore be excluded, but it does not appear to be the main target. We next used the MEF system described above to verify the need of STIM1/2 for channel opening by these compounds. At it can be observed in Figure 5C, 2T strongly potentiated/induced calcium entry in both systems, suggesting that STIM is dispensable for this effect and the putative molecular target could be an Orai protein. We also investigated whether 2T and 3G were use-dependent, i.e. required the triggered opening of the Orai channel to elicit their effects. To do this, we monitored intracellular Ca2+ in resting BV2, Hek or Jurkat cells in the presence of extracellular Ca2+. While 3G 10 µM did not elicit any significant calcium entry compared to control in the 800 seconds of observation in any of the three cell lines, 2T-treated cells displayed a slow rise of Ca2+, which started shortly after the addition of the compound (see Supporting Information). These data suggest that 2T is an activator/channel opener while 3G is a potentiator/enhancer, but further characterizations will be required in the future to fully elucidate the mechanism of 2T and 3G. It should be noticed that 2-APB behaves differently as a SOCE enhancer in Orai1- and Orai3-expressing cells32 and it will be therefore of interest to test these compounds in similar conditions.


12


Page 14 of 89

Selectivity of 1S, 2T and 3G It has been reported that Pyr compounds may also affect other channels.15-18 In this respect, we tested the activity of Pyr3, Pyr6, 1S, 2T and 3G on voltage-operated channels, TRPV1 and TRPM8 channels that have been shown previously to be affected by SOCE inhibitors. For voltage-operated Ca2+-channels we used primary cultures of mouse cerebellar granule cells challenged with 50 mM KCl in the presence or absence of the compounds. As shown in Figure 6A, at 10 µM 1S, 2T and 3G did not influence voltage-dependent calcium entry, while Pyr3 and Pyr6 reduced entry by about 50%. When testing TRPV1 in TRPV1-overexpressing Hek cells challenged with capsaicin (100 nM), Pyr3 had no effect, while 1S and Pyr6 significantly affected the response (Figure 6B). Finally, we tested TRPM8 inhibition by using TRPM8-overexpressing Hek cells challenged with the known agonist menthol (100 µM). As shown in Figure 6C, 1S, 2T, 3G, Pyr3 had no effect on the response, while Pyr6 significantly reduced menthol-mediated calcium rise. Synthesis of analogues of compound 1S and characterization 1S appears like an inhibitor of SOCE with different peculiarities compared to Pyr compounds. In particular, it does not have an effect on voltage-dependent channels and is less cytotoxic, although it inhibits TRPV1 channels. We therefore next focused our efforts on performing a preliminary SAR study of this compound (Table 3 and 4). First of all, we investigated whether the triazole ring behaved merely as an isostere of the amide group or played a role in the interaction with the SOCE machinery (Table 3). To this aim, 1S analogues displaying both the direct (19) and inverse (22) amide were synthesized, according to Scheme 6. The amine and the carboxylic acid were coupled, while protecting and deprotecting the additional carboxylic group. We also synthesized the corresponding 1,5-disubstituted triazole (23) using a ruthenium-based catalyst (Scheme 6).


13

Page 15 of 89 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60


Then, the ethyl ester portion of 1S was modified (Table 4). In particular, intermediate 7 was transesterified (24, 25), reduced to amine (26, 27), converted into azide (28, 29) and clicked with alkyne S to give the final methyl ester 30 and isopropyl ester 31 (Scheme 7). Alternatively, intermediate 1 was hydrolized to 32, coupled with different alcohols (33-38) and clicked with alkyne S, leading to a series of structurally different esters (39-44) (Scheme 7). Moreover, the ethyl ester of intermediate 8 was reduced in the presence of LiAlH4, converted into azide 45 and clicked with alkyne S to give the final primary alcohol 46 (Scheme 7). Intermediate 32 was coupled with isopropylamine and then clicked with alkyne S, yielding the secondary amide 48 (Scheme 7). The ethyl ester of compound 1S was reacted with aqueous ammonia to give the primary amide 49 and hydrolized leading to the corresponding carboxylic acid 50 (Scheme 8). Last, we investigated whether the carboxylic moiety of compound 1S was tolerant to substitution with acyl methansulfonamide 51 (Scheme 8), methyl ester 58, methyl ketone 59, primary amide 60, primary alcohol 61, sulfonamide 62 and hydroxamic acid 63 (Scheme 9). To this aim, the corresponding alkynes 52-56 were prepared by a Sonogashira coupling and deprotection, while alkyne 57 was synthesized by coupling reaction using O-(trimethylsilyl)hydroxylamine and deprotection (see Supporting Information). The synthesized analogues were screened in the same manner as described above after purification by column chromatography and the results are displayed in Table 3 and 4. These included cell viability via the MTT assay at 10 μM and determination of the IC50 for the inhibition of SOCE for the most active compounds (see Supporting Information for concentration-response curves of 31 and 39). From these data, the first observation is that the triazole ring, the key novelty added in this contribution, does not merely behave as an isostere of the amide group, but plays a pivotal role in the modulation of SOCE. Indeed, when substituted with both its direct and the inverse


14


Page 16 of 89

amide (19 and 22), a drop in activity surprisingly occurs. Second, the 1,4-disubstituted triazole ring cannot be replaced with the 1,5-disubstituted analogue 23. Third, the methyl ester 30 and the isopropyl ester 31 are more active compared to the ethyl ester 1S, the pentan-2-yl ester 39 inhibits SOCE to the same extent, while the other synthesized esters (40-44) lose the ability to act on SOCE. Furthermore, the ethyl ester cannot be replaced by a primary alcohol (46) or by an amide (48, 49). Finally, the carboxylic group moiety is not tolerant to the substitution with other functionalities (51, 58-62), except for the hydroxamic acid 63, which is endowed with remarkable activity, but significantly affects cell viability at 10 µM. Given that the ester group in 1S might be susceptible to hydrolysis, we decided to investigate whether the corresponding carboxylic acid retained activity. As it can be seen, 50 is not active, demonstrating that the ester group is necessary for the inhibition of SOCE. Therefore, we decided to investigate the hydrolytic stability of 1S and the esters selected according to their activity on SOCE (30, 31, 39, 43) in mouse plasma. As it can be seen (Table 3, 4 and Supporting Information for full data) the short linear esters (Pyr3, 1S and 30) and the (benzyloxy)carbonyl 43 underwent fast hydrolysis, suggesting that they might not be good hit compounds for systemic use. Conversely, the branched esters 31 and 39 showed an overall good stability in plasma, with a residual substrate after 30 minutes of 87.7 and 97.8%, respectively. Given that the plasma stability of Pyr3 was poor (20.4% residual substrate after 30 min), 31 and 39 appeared as major improvements in this respect. We therefore decided to evaluate their metabolism in mouse liver homogenates. In mouse liver S9 fractions (MLS9), their hydrolytic stability was confirmed with the residual substrate after 1 hour being 81.3% and 73.7% for 31 and 39, respectively (see Supporting Information). We next investigated the in vitro oxidative metabolism of the two compounds by performing incubations


15

Page 17 of 89 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60


in the presence of NADPH. Alternatively, given the presence of a carboxyl acid moiety, the formation of acylglucuronide metabolites was assessed by incubating the compounds in mouse liver microsomes (MLM) activated by UDPGA (see Supporting Information). Overall, hydrolysis of the ester function was the main metabolic pathway in liver metabolism, as no significant differences in residual substrate were observed in the presence or absence of NADPH or UDPGA. However, minute amounts of other metabolites (

Pyrtriazoles, a Novel Class of Store-Operated Calcium Entry Modulators

Recommend Documents